FIRST AMERICAN HEALTH CONCEPTS INC
10KSB40/A, 2000-06-20
BUSINESS SERVICES, NEC
Previous: FIRST AMERICAN HEALTH CONCEPTS INC, 10QSB/A, EX-27, 2000-06-20
Next: FIRST AMERICAN HEALTH CONCEPTS INC, 10KSB40/A, EX-27, 2000-06-20



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  FORM 10-KSB/A

[X] Annual Report Pursuant to Section 13 or 15(d) of the Securities
    Exchange Act of 1934.

    For the fiscal year August 1, 1998 to July 31, 1999.

[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities
    Exchange Act of 1934.

    For the transition period from N/A to N/A .

                        Commission File Number: 0-15207

                      FIRST AMERICAN HEALTH CONCEPTS, INC.
                 (Name of small business issuer in its charter)

       ARIZONA                                           86-0418406
(State of Incorporation)                    (IRS Employer Identification Number)

7776 South Pointe Parkway West, Suite 150, Phoenix, Arizona       85044-5424
        (Address of principal executive offices)                  (Zip Code)

                                 (602) 414-0300
                (Issuer's telephone number, including area code)

           Securities Registered Pursuant to Section 12(b) of the Act:

                                      NONE

           Securities Registered Pursuant to Section 12(g) of the Act:

                         Common Stock without par value
                                (Title of class)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Securities  Exchange  Act  during the past 12 months (or for
such shorter period that the registrant was required to file such reports),  and
(2) has been subject to such filing  requirements  for the past 90 days.
Yes [X] No [ ]

Check if there is no disclosure of delinquent  filers in response to Item 405 of
Regulation  S-B is not  contained  in  this  form,  and no  disclosure  will  be
contained,  to the  best of  Registrant's  knowledge,  in  definitive  proxy  or
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB. [X]

Issuer's revenue for the fiscal year ended July 31, 1999 was $8,447,291.

Registrant's  Common Stock  outstanding at October 19, 1999 was 2,604,736 shares
after  deducting  468,102 shares of treasury  stock. At such date, the aggregate
market value of Registrant's Common stock held by non-affiliates, based upon the
closing  price  at  which  such  stock  was  sold  on  AMEX  on  such  date  was
approximately $3,933,256.

                       DOCUMENTS INCORPORATED BY REFERENCE

Portions of  Registrant's  definitive  Proxy Statement for the Annual Meeting of
Shareholders to be held on December 10, 1999 are incorporated in Part III as set
forth herein.
<PAGE>
                                TABLE OF CONTENTS

PART I                                                                      PAGE
                                                                            ----

Item 1.  Description of Business                                              3
Item 2.  Description of Property                                              3
Item 3.  Legal Proceedings                                                    4
Item 4.  Submission of Matters to a Vote of Security Holders                  4

PART II

Item 5.  Market for Common Equity and Related Stockholder Matters             4
Item 6.  Management's Discussion and Analysis                                 5
Item 7.  Financial Statements (Restated)                                      8
Item 8.  Changes in and Disagreements with Accountants on Accounting and
         Financial Disclosure                                                 8

PART III

Item 9.  Directors, Executive Officers, Promoters and Control Persons;
         Compliance with Section 16 (a) of the Exchange Act                   9
Item 10. Executive Compensation                                               9
Item 11. Security Ownership of Certain Beneficial Owners and Management      10
Item 12. Certain Relationships and Related Transactions                      10
Item 13. Exhibits and Reports on Form 8-K                                    10

Signatures                                                                   11

                                       2
<PAGE>
                                     PART I

FIRST AMERICAN HEALTH CONCEPTS, INC.

     This amended filing has been made to reflect the effect of a restatement of
the Company's consolidated financial statements as discussed in Note 12 of notes
to the consolidated financial statements.

ITEM 1. DESCRIPTION OF BUSINESS

BUSINESS DEVELOPMENT

     First  American  Health  Concepts,  Inc.  ("FAHC"  or  the  "Company")  was
incorporated  in Arizona in 1981 and first  offered  common  stock  publicly  in
October  1985.  FAHC  markets and  administers  vision care  programs  under the
registered trade names of Eye Care Plan of America(R) and ECPA(R).

     Initially,  FAHC's  growth  came from the  development  of a direct  access
preferred  pricing  program.  This  program  is  delivered  through  a  national
preferred  provider  (PPO)  network  of  independent  and  retail  optometrists,
opticians and  ophthalmologists.  The most significant  growth in the past three
years has occurred in the self funded products and the insured products that are
underwritten by primary insurance  carriers.  Prior to January 1998, the Company
received  administrative fee revenue in association with the insured revenue. In
January  1998,  FAHC  formed  a  captive  reinsurance  company,  First  American
Reinsurance Company (FARC) in order to share in the underwriting  profits of the
primary carrier.

BUSINESS OF ISSUER

     FAHC markets and administers three related products under its d.b.a.  ECPA;
a direct access preferred  pricing program,  an insured program  underwritten by
various insurance carriers and a self funded program.

     The direct access preferred pricing program  membership  accesses providers
directly and obtains  savings on products  and services  based upon fee schedule
agreements.  The insured and self funded  programs are similar.  Members  access
providers  directly  and pay only a co-payment  (if  applicable)  for  scheduled
vision care benefits.  The Company  performs the claims  administration  for the
underwriting carrier and interacts directly with the providers. Insured benefits
are underwritten by Security Life Insurance Company of America (founded in 1956,
Minnetonka,  Minnesota) and The MEGA Life and Health Insurance  Company (founded
in 1982, Oklahoma City, Oklahoma).

     The preferred  pricing,  insured and self funded  products are  distributed
both directly and through a broker/agent network to employers and other sponsors
having  access to ten or more  employees,  clients or  customers.  Existing  and
potential  sponsors  include employer groups,  insurance  carriers,  third party
administrators,  health  maintenance  organizations,  multiple  employer trusts,
financial  institutions,  associations,  labor unions,  governmental  bodies and
political subdivisions.

ITEM 2. DESCRIPTION OF PROPERTY

     The Company  leases an  aggregate  of 17,000  square feet of Class B office
space for its sales  and  administrative  offices.  The  Company's  headquarters
office in Phoenix,  Arizona is leased at an effective  rate of $21,902 per month
with an  expiration  date of  September  2002.  Sales  offices  are  located  in
California,  Colorado,  Georgia,  Massachusetts  and Ohio with  effective  rates
ranging from $400 to $1,800 per month and lease  expiration  dates through March
2002.

     The  Company  maintains  cash  reserves  for  use in  corporate  expansion,
financing growth of its business and general  corporate  purposes.  FAHC invests
excess cash in interest-bearing securities including U.S. Treasuries,  generally
with  maturities  of less than one year.  The  Company  also  invests  in equity
securities consisting of preferred stock. Investments are governed by guidelines
established  by a committee  of the Board of  Directors  and are  generally  not
limited by type.

                                       3
<PAGE>
ITEM 3. LEGAL PROCEEDINGS

     None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     None

                                     PART II

                      FIRST AMERICAN HEALTH CONCEPTS, INC.

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED

STOCKHOLDER MATTERS

       Common                       Trading Range During the
       Stock Prices                   Years Ended July 31,
                               -----------------------------------
                                   1999                  1998
                               ------------          -------------
                               High     Low          High      Low
                               ----     ---          ----      ---
       Quarter Ended:
          October 31          $4 3/8   $3 1/2       $5       $2 7/8
          January 31          $4 1/4   $3 1/2       $5 1/2   $2 7/8
          April 30            $5       $2 7/8       $5       $3 1/4
          July 31             $4 1/4   $2 3/4       $5 1/4   $3 1/2

     Beginning  August  4,  1999 the  Company's  common  stock is  traded on the
American  Stock  Exchange  (symbol:  FAH) in order to take advantage of the AMEX
specialist  system.  From  February  27, 1995 to August 3, 1999,  the  Company's
common stock has traded on the NASDAQ  National  Market System  (symbol:  FAHC).
Prior to that date,  common  shares were  traded on the NASDAQ  Over-the-Counter
Market. On October 4, 1999 there were  approximately 102 shareholders of record,
not including those shares held in street name. The Company has neither declared
nor paid any cash  dividends to date and does not plan to do so in the immediate
future.

                                       4
<PAGE>
ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS

FORWARD-LOOKING STATEMENTS

     This Report on Form 10-KSB contains forward-looking  statements.  The words
"believe,"  "expect,"  "anticipate,"  and  "project,"  and  similar  expressions
identify  forward-looking  statements,  which  speak  only  as of the  date  the
statement was made.  Such  forward-looking  statements are within the meaning of
that term in Section 27A of the Securities Act of 1933, as amended,  and Section
21E of the  Securities  Exchange Act of 1934, as amended.  Such  statements  may
include,  but are not limited to,  projections  of  revenues,  income,  or loss,
capital expenditures, plans for future operations, financing needs or plans, the
impact of inflation and plans relating to the foregoing.

RESULTS OF OPERATIONS

     During  2000,  subsequent  to the issuance of the  Company's  July 31, 1999
audited consolidated financial statements,  certain accounting items that affect
those consolidated financial statements were identified as requiring adjustment.

     The  need  for  adjustment  was  identified  in  the  following  items:  an
unrecorded  claims  reserve of  $261,000;  a tax credit of  $109,000  originally
recorded in fiscal 1999 that the  Company  now knows will not be  realized;  and
adjustments further reducing general expenses by $171,000. In addition, $163,000
of costs  were  identified  that do not  qualify  for  deferral.  This item only
affects retained earnings accumulated in prior years.

     After  restatement of these items, the net income of the Company is reduced
by $165,000 ($0.06 per share) in fiscal 1999.  Financial  statement balances and
footnote presentation have been restated accordingly.

     First American Health Concepts,  Inc. ("FAHC" or the "Company") reported an
8% increase in operating  revenues,  with a growth from  $7,809,000  for 1998 to
$8,447,000  for 1999.  Products  comprising  total  operating  revenues  include
non-insured  product of $4,446,000,  insured and self-funded product revenues of
$3,360,000  and other  incidental  income  of  $641,000.  While the  non-insured
product still  generated  the largest  portion of the  Company's  revenues,  its
revenues did decrease 6% from the year ended July 31, 1998.  This  decrease is a
reflection  of  changing  market  demand for vision  care  preferred  pricing or
"discount"  programs that the Company has been  anticipating  for several years.
Market research continues to show an increasing demand for full-benefit, managed
vision  care  programs.   The  Company's  $1,296,000  increase  in  insured  and
self-funded  product revenues  supports this research.  The Company  anticipates
that revenues from its managed  vision care programs  (insured and  self-funded)
will continue to be the source of growth in the future.  This is the reason that
FARC was formed in January 1998.  FARC assumes a portion of the insured  premium
from the  underwriting  carrier  through a Quota  Share  agreement.  The premium
assumed under this  agreement  during fiscal 1999 was  $1,396,000 of the insured
and self-funded revenues discussed above. The premium assumed during fiscal 1998
was $398,000.

     The Company does not experience  significant seasonal  fluctuations.  While
the non-insured  product membership is renewed annually,  most fees are remitted
and recognized as revenue monthly.  The insured product and self-funded products
are  calculated and billed  monthly and  recognized  accordingly.  The Company's
largest growth in membership,  and resultant  revenues,  normally  occurs in its
second and third  quarters  due to the  significant  number of  companies  whose
benefits are coordinated with the calendar year.

     Total  operating   expenses  increased  8%,  from  $7,366,000  in  1998  to
$7,984,000 in 1999. Total operating  expense  increased as a percentage of total
operating  revenue from 94% in 1998 to 95% in 1999.  The  increases in operating
expenses in recent years have  reflected  an  investment  in the  infrastructure
necessary to support managed vision care.

                                       5
<PAGE>
     Sales and marketing expenses were $1,839,000 in 1998 compared to $1,304,000
in  1999.  This  29%  decrease  was the  result  of a cost  containment  program
implemented  in 1998.  The program  realigned the sales staff,  centralized  the
sales  support  function and  streamlined  the sales  process  that  resulted in
reduced salaries,  travel and administrative expense. Expenses decreased despite
the addition of sales staff.

     Direct membership expenses decreased 10%, from $2,758,000 for 1998 compared
to $2,477,000 for 1999.  These costs are associated  with supplying  vision plan
members with membership  materials,  maintaining a national provider network and
administering claims processing functions. The decrease was achieved through the
realization  of operating  efficiencies  gained  through the  utilization of the
managed care information system that was fully implemented last fiscal year.

     General and  administrative  expenses  were  $2,453,000 in 1998 compared to
$2,884,000 in 1999. The increase was due to the addition of staff and associated
expenses  required to complete the specialized  Knox-Keene Health Care licensing
and begin preparation for ECPA of California to administer vision plans.

     Reinsurance  expense increased from $257,000 in 1998 to $1,268,000 in 1999.
Reinsurance  expense  is  the  claims,   marketing  and  administration  expense
associated  with the assumed  reinsurance  premium.  FARC was created in January
1998 and only assumed insured  business  incepting during or after January 1998,
all other insured  revenue was fee related and only included  overhead  expense.
All new insured  business  written in 1999, plus all business written January 1,
1998 and  later,  was  subject  to the Quota  Share  agreement  in fiscal  1999.
Furthermore,  beginning July 1, 1999 all business  written prior to January 1998
is also  subject  to the Quota  Share  agreement.  Therefore,  the  increase  in
reinsurance expense corresponds to the increase in reinsurance revenue.

     Interest  income was  $163,000 in 1998  compared  to $146,000 in 1999.  The
decrease is due to lower average invested balances.

LIQUIDITY AND CAPITAL RESOURCES

     Working  capital was  $2,869,000 and the current ratio was 2.2 to 1 at July
31, 1999. Cash and cash equivalents and marketable investment securities totaled
$1,866,000.

     The Company's cash and cash  equivalents  increased  $283,000 from the 1998
balance to $1,626,000 at July 31, 1999. The Company's  principal source of funds
for the year ended July 31, 1999 was cash flow from investment activities.

     Management anticipates moderate expansion in 2000 through capital additions
and infrastructure  expenditures to accommodate growth as it occurs. The Company
believes its ongoing cash flow will support all anticipated capital expenditures
and operating expenses.

YEAR 2000 ISSUE

     The  Company  formed a Year 2000 Task Force over two years ago to perform a
comprehensive review of its core business applications  (information  technology
("IT") and  non-IT).  The review was  performed  in  conjunction  with  planning
efforts to enhance  the  Company's  existing  infrastructure  and to support the
Company's  addition of full-benefit  insured and  self-funded  group vision care
products.  From this effort, a managed vision care software system was purchased
to support the new products and to replace the software  system utilized for the
vision care  savings  product.  In  addition,  other  information  systems  were
identified  for upgrade.  In no case was a system  replaced or purchased  solely
because of Year 2000  issues.  Thus,  the Company  does not believe the costs of
these software replacements are specifically Year 2000 related.

                                       6
<PAGE>
     The Company is currently testing improvements, related to Year 2000 issues,
from its  software  vendors.  The  testing is  approximately  90%  complete  and
implementation is expected to be complete by November 1999. The Company believes
that it will not incur additional  material costs in the  implementation  of the
improvements.

     The Company is also working  with its non-IT  systems  vendors.  Testing on
these modifications is complete and implementation is expected by November 1999.

     The  Company  continues  to verify  Year 2000  readiness  of third  parties
(vendors and customers)  with whom the Company has material  relationships.  The
Company will formulate a contingency plan if it identifies  vendors or customers
that it feels will not be compliant.

     The Year 2000 issue is the result of computer  programs being written using
two digits (rather than four) to define the applicable year.  Computer  programs
that have time-sensitive  software may not recognize dates beginning in the year
2000, which could result in miscalculations or system failures.

CONTRACTUAL ARRANGEMENTS

     The  Company's  insured line of business is  underwritten  by Security Life
Insurance  Company of  America  (SLICA)  and The MEGA Life and Health  Insurance
Company  (MEGA).  According to the management  agreement with SLICA (dated April
15, 1992),  SLICA is  responsible to "process,  investigate,  settle and pay all
claims  arising,"  including  claims  underwritten  by the MEGA Life and  Health
Insurance  Company.  The Company  assumes  both  premium and risk of loss on the
policies  under  the terms of a  Reinsurance  Agreement  between  FARC and SLICA
(dated January 1, 1998). The risk of loss is based upon the schedule of benefits
attached  to each  policy.  Under  the  terms of the  agreement,  SLICA  retains
adequate cash reserves on a funds withheld basis.

LICENSURE ISSUES

     The  Company  markets  and  administers  insured  vision care under its own
licenses or the  license of its  insurance  carrier in each state where  insured
vision  care is  provided.  To meet  legal and  regulatory  requirements,  a new
subsidiary,  First  American  Administrators,  Inc. (FAA) was created to provide
these  services.  Both  FAHC  and FAA  hold  various  third-party  administrator
licenses in markets where they do business. The Company holds 20 licenses at the
present  time,  10 states do not  require a  license.  The  Company  anticipates
completing the licensing process in the remaining states in 2000.

     The primary licensing activity  involving FAHC's subsidiary,  Eye Care Plan
of  American  -  California,  Inc.  (ECPA-CA)  resulted  in  the  filing  of  an
application  for  licensure as a  Specialized  Knox-Keene  Health Care  Services
Organization  in the State of  California.  Upon  review  and  approval  of this
application  by the  California  Department of  Corporations,  ECPA-CA will also
provide  a  complete  complement  of  vision  care  services  in  the  State  of
California.

RECENT ACCOUNTING PRONOUNCEMENTS

     In April 1998, the AICPA Accounting  Standards  Executive  Committee issued
SOP 98-5, REPORTING THE COSTS OF START-UP ACTIVITIES,  which requires that costs
incurred during start-up activities,  including  organization costs, be expensed
as incurred.  Application of the SOP should be as of the beginning of the fiscal
year in  which  the  SOP is  first  adopted,  and it  should  be  reported  as a
cumulative effect of a change in accounting principle.  This new standard, which
will be effective for the Company for the fiscal year ending July 31, 2000,  was
evaluated  by  management  and any  relevant  costs will be expensed  during the
quarter ending October 31, 1999.

                                       7
<PAGE>
     There are certain matters affecting  accounting and disclosure,  which have
been  pronounced  by  authoritative  accounting  bodies  other  than  the  FASB.
Management  has evaluated  and  implemented  those  currently  required,  and is
evaluating the applicability and impact of those pronouncements that are not yet
effective.

ITEM 7. FINANCIAL STATEMENTS (RESTATED)

     The  Company's  financial  statements  (restated)  and  notes  thereto  are
included in this report beginning at page 12.

ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
        FINANCIAL DISCLOSURE

     None.

                                       8
<PAGE>
                                    PART III

ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS; COMPLIANCE
        WITH SECTION 16 (a) OF THE EXCHANGE ACT

     The  information  called for by this Item,  with respect to directors,  and
with respect to officers regarding compliance with Section 16(a) is incorporated
by  reference  to the  Company's  1999  Definitive  Notice of Meeting  and Proxy
Statement.

                                        Current Title and Positions
Executive Officer     Age at 7/31/99    Held During the Last Five Years
-----------------     --------------    -------------------------------

John A. Raycraft             52         Chief Executive  Officer since May 1993;
                                        President  since  1992;  Executive  Vice
                                        President from 1991 to 1992.

Laura J. Arnold              38         Vice  President  of  Provider  Relations
                                        since August 1994;  Manager since August
                                        1993;  Director  of Vision  and  Hearing
                                        Plan Services/Southwestern Benefit Plans
                                        and  Network  Development  with  AVESIS,
                                        Inc. prior to joining the Company.

Deborah L. Brady             42         Vice President of  Administration  since
                                        June 1997; Membership Accounting Manager
                                        for FHP  Health  Care from 1996 to 1997,
                                        Operations  Manager for CIGNA HealthCare
                                        from 1995 to 1996, Director & Manager of
                                        Enrollment  Processing  for  PCS  Health
                                        Systems, Inc. from 1993 to 1995.

James D. Hyman               54         Vice  President of  Marketing  and Sales
                                        since  August  1998;  a Principal & Vice
                                        President of Managed Care for Physicians
                                        Eyecare Network, Inc. from 1993 to 1996,
                                        Vice  President of  Marketing  for Davis
                                        Vision, Inc. from 1987 to 1993.

Carolyn Hall                 59         Secretary  and  Treasurer   since  1988;
                                        Secretary since 1987.

Margaret Eardley             30         Vice  President  of  Finance  and  Chief
                                        Financial  Officer  since  October 1998;
                                        Vice President of Finance for Cedar Hill
                                        Assurance  Company  from  1997 to  1998,
                                        Vice  President &  Treasurer,  Assistant
                                        Vice  President  of Finance  and Finance
                                        Manager for Republic  Western  Insurance
                                        Company from 1991 to 1997.

Burt Leonard                 45         Director of  Information  Systems  since
                                        June   1999;   President   for   Western
                                        Software Technologies from 1993 to 1999.

ITEM 10. EXECUTIVE COMPENSATION

     The information called for by this Item is incorporated by reference to the
Company's 1999 Definitive Notice of Meeting and Proxy Statement.

                                       9
<PAGE>
ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

     The information called for by this Item is incorporated by reference to the
Company's 1999 Definitive Notice of Meeting and Proxy Statement.

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

     The Company has an outstanding  note  receivable due from the President and
Chief Executive Officer.  The note is secured by an insurance policy on the life
of the officer. The terms of the note require annual installments through August
1,  1999.  The  balance  of the note on July 31,  1999 was  $28,794.  Additional
information  called  for by  this  Item  is  incorporated  by  reference  to the
Company's 1999 Definitive Notice of Meeting and Proxy Statement.

ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K

     (a) Exhibits

   Exhibit
   Number         Description                         Method of Filing
   ------         -----------                         ----------------
    3-A   Articles of Incorporation of the      Incorporated by reference to
          Company as amended                    Exhibit 3-A of 1990 10-K.

    3-B   Bylaws of the Company                 Incorporated by reference to
                                                Exhibit 3-B of 1992 10-K.

    4-A   Specimen Stock Certificate            Incorporated by reference to
                                                Exhibit 4-A of S-18 33-00118-LA

    28    Notice of Meeting and Proxy           Incorporated by reference to the
          Statement                             Company's 1999 Definitive Notice
                                                and Proxy Statement

     (b) Reports on Form 8-K

          No reports on Form 8-K have been filed  during the last quarter of the
     period covered by this report.

                                       10
<PAGE>
                                   SIGNATURES

In accordance  with Section 13 or 15 (d) of the Exchange Act, the registrant has
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                        FIRST AMERICAN HEALTH CONCEPTS, Inc.
                                                    (Registrant)

Date: June 20, 2000
                                       By: /s/ James D. Hyman
                                           --------------------------------
                                           James D. Hyman
                                           President and Chief Executive Officer

In  accordance  with the Exchange  Act, this report has been signed below by the
following  persons on behalf of the  registrant and in the capacities and on the
dates indicated.

  Signature                       Title                                 Date
  ---------                       -----                                 ----

/s/ James D. Hyman             President and                          6/20/00
-----------------------        Chief Executive Officer
(James D. Hyman)


/s/ James Gresko               Vice President Finance and Chief       6/20/00
-----------------------        Financial Officer
(James Gresko)

/s/ John R. Behrmann           Chairman of the Board                  6/20/00
-----------------------
(John R. Behrmann)

/s/ Robert J. Delsol           Director                               6/20/00
-----------------------
Robert J. Delsol

/s/ Thomas B. Morgan           Director                               6/20/00
-----------------------
(Thomas B. Morgan)

/s/ Robert M. Topol            Director                               6/20/00
-----------------------
(Robert M. Topol)

                                       11
<PAGE>
                      FIRST AMERICAN HEALTH CONCEPTS, INC.
                                AND SUBSIDIARIES

                        Consolidated Financial Statements

                                  July 31, 1999
                                   (Restated)

                   (With Independent Auditors' Report Thereon)


                                       12
<PAGE>
                          INDEPENDENT AUDITORS' REPORT

The Board of Directors and Shareholders
First American Health Concepts, Inc.:

We have audited the accompanying  consolidated balance sheet (restated) of First
American  Health  Concepts,  Inc. and  subsidiaries as of July 31, 1999, and the
related  consolidated  statements  of income  (restated),  shareholders'  equity
(restated),  and cash  flows  (restated)  for each of the years in the  two-year
period ended July 31, 1999.  These  consolidated  financial  statements  are the
responsibility of the Company's management.  Our responsibility is to express an
opinion on these consolidated financial statements based on our audits.

We  conducted  our  audits  in  accordance  with  generally   accepted  auditing
standards.  Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement.  An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements.  An audit also includes
assessing the  accounting  principles  used and  significant  estimates  made by
management,  as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.

In our opinion,  the consolidated  financial  statements  (restated) referred to
above present fairly, in all material respects,  the financial position of First
American  Health  Concepts,  Inc. and  subsidiaries  as of July 31, 1999 and the
results  of their  operations  and their cash flows for each of the years in the
two-year  period  ended July 31,  1999 in  conformity  with  generally  accepted
accounting principles.

As discussed further in Note 12, the consolidated financial statements have been
restated to reflect the correction of certain accounting errors.

                                      /s/ KPMG LLP


Phoenix, Arizona
October 13, 1999, except for Note 12,
which is as of June 7, 2000

                                       13
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                           Consolidated Balance Sheet
                                  July 31, 1999
                                   (Restated)

                                     ASSETS
Current assets:
  Cash and cash equivalents                                         $ 1,625,874
  Marketable investment securities (note 2)                             239,875
  Member fees receivable, net of allowance of $37,870                 2,457,970
  Note receivable-- officer (note 3)                                     28,794
  Deferred costs                                                        141,055
  Prepaid expenses                                                      149,950
  Income taxes receivable                                               356,201
  Other current assets                                                  175,766
                                                                    -----------
         Total current assets                                         5,175,485
                                                                    -----------

Property and equipment:
  Office furniture and fixtures                                         318,986
  Computers and office equipment                                      3,543,137
  Leasehold improvements                                                201,083
                                                                    -----------
                                                                      4,063,206
  Less accumulated depreciation and amortization                     (2,300,889)
                                                                    -----------
         Net property and equipment                                   1,762,317
                                                                    -----------

Deferred costs                                                        1,011,305
                                                                    -----------

         Total assets                                               $ 7,949,107
                                                                    ===========

                      LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
  Accounts payable                                                  $    60,925
  Claims payable                                                        261,000
  Bank loan, current (note 7)                                            21,100
  Accrued expenses                                                      168,448
  Deferred tax liability                                                693,694
  Deferred revenue                                                    1,101,638
                                                                    -----------
         Total current liabilities                                    2,306,805

Commitments and contingencies (notes 4, 7, 10 and 11)

Shareholders' equity (notes 6 and 7):
  Common stock, no par value; authorized, 8,000,000 shares;
   issued 3,072,838 shares                                              757,296
  Additional paid-in capital                                          2,565,067
  Retained earnings                                                   3,839,128
  Unearned ESOP shares (note 7)                                         (22,560)
  Net unrealized loss on marketable investment securities (note 2)      (10,897)
                                                                    -----------
                                                                      7,128,034
  Treasury stock, at cost, 468,102 shares                            (1,485,732)
                                                                    -----------
         Total shareholders' equity                                   5,642,302
                                                                    -----------

         Total liabilities and shareholders' equity                 $ 7,949,107
                                                                    ===========

See accompanying notes to consolidated financial statements.

                                       14
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                        Consolidated Statements of Income

                       Years ended July 31, 1999 and 1998

                                                      1999              1998
                                                  -----------        ----------
                                                   (Restated)
Operating revenues:
  Fee revenues                                    $ 7,051,722         7,411,460
  Reinsurance revenues                              1,395,569           397,662
                                                  -----------        ----------
         Total operating revenues                   8,447,291         7,809,122

Operating expenses:
  Sales and marketing expenses                      1,304,004         1,838,767
  Direct membership expenses                        2,477,132         2,757,550
  General and administrative expenses               2,883,837         2,452,586
  Reinsurance expense                               1,267,837           257,379
  ESOP charges (note 7)                                50,770            59,951
                                                  -----------        ----------
         Total operating expenses                   7,983,580         7,366,233
                                                  -----------        ----------

         Operating income                             463,711           442,889
                                                  -----------        ----------
Non-operating income (expense):
  Interest income                                     146,170           163,164
  Interest expense                                     (6,725)          (16,286)
                                                  -----------        ----------
         Total non-operating income                   139,445           146,878
                                                  -----------        ----------
         Income before income taxes                   603,156           589,767

Income taxes (note 9)                                 224,935           239,049
                                                  -----------        ----------

         Net income                               $   378,221           350,718
                                                  ===========        ==========
Net income per share - basic                      $      0.15              0.14
                                                  ===========        ==========
Net income per share - diluted                    $      0.14              0.14
                                                  ===========        ==========
Weighted average common and equivalent
  shares outstanding - basic                        2,598,270         2,559,750
                                                  ===========        ==========
Weighted average common and equivalent
  shares outstanding - diluted                      2,627,541         2,559,750
                                                  ===========        ==========

See accompanying notes to consolidated financial statements.

                                       15
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                 Consolidated Statements of Shareholders' Equity

                             July 31, 1999 and 1998
                                   (Restated)

<TABLE>
<CAPTION>
                                                                                    Net Unrealized
                                                                                    Gain (Loss) on
                          Outstanding           Additional                Unearned    Marketable                  Total
                            Common     Common    Paid-in      Retained      Esop      Investment   Treasury    Shareholders'
                            Shares     Stock     Capital      Earnings     Shares     Securities     Stock        Equity
                           ---------  --------  ----------   ----------   ---------    --------   -----------   ----------
<S>                        <C>        <C>       <C>          <C>          <C>          <C>        <C>           <C>
Balances at July 31, 1997  2,544,736  $655,296  $2,552,223   $3,273,102   $(175,164)   $  4,923   $(1,485,732)  $4,824,648
Effect of restatement for
 deferred costs                   --        --          --     (162,913)         --          --            --     (162,913)
                           ---------  --------  ----------   ----------   ---------    --------   -----------   ----------
Restated balance at
 July 31, 1997             2,544,736   655,296   2,552,223    3,110,189    (175,164)      4,923    (1,485,732)   4,661,735

Stock options exercised       20,000    26,250          --           --          --          --            --       26,250
Net unrealized (loss)
 on marketable
 investment securities            --        --          --           --          --      (2,875)           --       (2,875)
Income tax benefit
 arising from employee
 stock option plan                --        --      21,393           --          --          --            --       21,393
Cost of ESOP shares
 released                         --        --     (19,268)          --      79,219          --            --       59,951
Net income                        --        --          --      350,718          --          --            --      350,718
                           ---------  --------  ----------   ----------   ---------    --------   -----------   ----------
Balances at July 31, 1998
 (Restated)                2,564,736   681,546   2,554,348    3,460,907     (95,945)      2,048    (1,485,732)   5,117,172

Stock options exercised       40,000    75,750          --           --          --          --            --       75,750
Net unrealized (loss)
 on marketable
 investment securities            --        --          --           --          --     (12,945)           --      (12,945)
Income tax benefit
 arising from employee
 stock option plan                --        --      33,333           --          --          --            --       33,333
Cost of ESOP shares
 released                         --        --     (22,614)          --      73,385          --            --       50,771
Net income                        --        --          --      378,221          --          --            --      378,221
                           ---------  --------  ----------   ----------   ---------    --------   -----------   ----------
Balances at July 31, 1999  2,604,736  $757,296  $2,565,067   $3,839,128   $ (22,560)   $(10,897)  $(1,485,732)  $5,642,302
                           =========  ========  ==========   ==========   =========    ========   ===========   ==========
</TABLE>

See accompanying notes to consolidated financial statements.

                                       16
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                      Consolidated Statements of Cash Flows

                       Years ended July 31, 1999 and 1998

<TABLE>
<CAPTION>
                                                                  1999             1998
                                                               -----------      ----------
<S>                                                            <C>                 <C>
                                                                (Restated)
Cash flows from operating activities:
 Net income                                                    $   378,221         350,718
 Adjustments to reconcile net income to net
  cash provided by (used in) operating activities:
  Depreciation                                                     541,802         519,319
  Income tax benefit arising from stock option plan                 33,333          21,393
  ESOP shares committed to be released                              50,771          59,951
  Provision for losses on accounts receivable                           --          37,870
  Increase in deferred taxes                                       118,069         310,677
  Changes in assets and liabilities:
   Increase in member fees receivable                             (887,854)       (482,259)
   Increase in deferred costs                                     (360,030)       (707,864)
   (Decrease) increase in prepaid expenses and
     other current assets                                           60,732         (94,271)
   Increase in income taxes receivable                            (116,116)        (31,583)
   (Decrease) increase in accounts payable                        (146,734)         23,184
   Increase in claims payable                                      261,000              --
   Decrease in accrued expenses                                     78,671         (37,243)
   Decrease in deferred revenue                                   (172,789)       (111,327)
                                                               -----------      ----------
         Net cash used in operating activities                    (160,924)       (141,435)
                                                               -----------      ----------
Cash flows from investing activities:
 Purchases of property and equipment                              (303,749)       (430,394)
 Purchases of marketable investment securities                    (250,772)       (380,709)
 Redemptions/sales of marketable investment securities           1,000,110       1,809,112
 Decrease in note receivable-- officer                              16,731          16,999
                                                               -----------      ----------
         Net cash provided by investing activities                 462,320       1,015,008
                                                               -----------      ----------
Cash flows from financing activities:
 Repayments of bank loan                                           (84,400)        (84,400)
 Repayments of capital lease obligation                             (9,631)        (20,350)
 Proceeds from exercised stock options                              75,750          26,250
 Purchases of treasury stock                                            --              --
                                                               -----------      ----------
         Net cash used in financing activities                     (18,281)        (78,500)
                                                               -----------      ----------
         Net increase in cash and cash equivalents                 283,115         795,073

Cash and cash equivalents, beginning of year                     1,342,759         547,686
                                                               -----------      ----------

Cash and cash equivalents, end of year                         $ 1,625,874       1,342,759
                                                               ===========      ==========
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the year for income taxes                     $     2,651              --
                                                               ===========      ==========
Cash paid during the year for interest                         $     4,554          13,418
                                                               ===========      ==========
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING ACTIVITIES:
Unrealized (loss) on marketable investment securities          $   (12,945)         (2,875)
                                                               ===========      ==========
</TABLE>

See accompanying notes to consolidated financial statements.

                                       17
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements
                             July 31, 1999 and 1998
                                   (Restated)

(1)  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     BUSINESS DESCRIPTION AND REVENUE RECOGNITION

     First  American  Health  Concepts,  Inc.  (FAHC  or the  Company)  receives
     membership  fees  through  its  various  Eye Care  Plan of  America  (ECPA)
     programs.  ECPA  Non-Insured  membership  generally is renewed annually and
     fees are remitted to the Company  monthly by sponsors,  based on the number
     of members  represented  by the sponsor.  Revenues are  recognized  monthly
     based  on  the  aggregate  number  of  members  reported  to  the  Company.
     Membership fees may also be remitted on an annual basis and, in such cases,
     are amortized  ratably to income over a twelve-month  period.  Premiums and
     fees related to ECPA Insured and ECPA  Self-Funded  Programs are calculated
     and billed on a monthly basis and recognized  accordingly.  The premium for
     these policies is remitted directly to the insurance carrier.  For policies
     incepting  prior to January 1, 1998,  the insurance  carrier remits fees to
     the Company on a monthly basis.  The Company created a captive  reinsurance
     company,  First  American  Reinsurance  Company  (FARC)  in  January  1998.
     Therefore,  for policies  incepting  after  January 1, 1998,  the insurance
     carrier  remits a quota  share  portion of the  premium to the Company on a
     monthly basis. Beginning July 1, 1999 all business written prior to January
     1998 is also subject to the Quota Share agreement.

     PRINCIPLES OF CONSOLIDATION

     The consolidated  financial  statements include the financial statements of
     the  Company  and its  three  wholly-owned  subsidiaries.  All  significant
     intercompany   balances   and   transactions   have  been   eliminated   in
     consolidation.

     CASH AND CASH EQUIVALENTS

     The Company  considers all highly liquid  financial  instruments  purchased
     with an original maturity of three months or less to be cash equivalents.

     DEVELOPMENT COSTS

     The Company  expenses its costs of developing the eye care provider network
     and sponsor network as they are incurred.

     MARKETABLE INVESTMENT SECURITIES

     Marketable  investment  securities  at July 31, 1999  consist of  preferred
     stock securities. Under the provisions of Statement of Financial Accounting
     Standards  (SFAS) No. 115,  ACCOUNTING FOR CERTAIN  INVESTMENTS IN DEBT AND
     EQUITY  SECURITIES,   the  Company  classifies  its  equity  securities  as
     available  for  sale  and  such  securities  are  recorded  at fair  value.
     Unrealized holding gains and losses on available-for-sale  securities,  net
     of related tax effects,  are excluded  from  earnings and are reported as a
     separate component of shareholders'  equity until realized.  Realized gains
     and losses on securities are included in earnings and are derived using the
     specific identification method for determining the cost of securities sold.

                                       18
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements

     DEFERRED COSTS

     The Company defers the direct costs of initiating  vision plan memberships.
     Such costs are amortized over a twelve-month  period,  which corresponds to
     the period utilized for measurement of membership fees. Direct  advertising
     costs are expensed as incurred.

     Non-current  deferred costs relate  primarily to direct  incremental  costs
     associated with entering key  geographical  locations which are capitalized
     until the  commencement  of  operations,  at which time they are charged to
     operations.

     PROPERTY AND EQUIPMENT

     Property and equipment are recorded at cost. Depreciation is provided using
     the  straight-line  method  over  estimated  useful  lives of three to five
     years.  Equipment  under  capital  leases and  leasehold  improvements  are
     amortized using the straight-line method over the shorter of the lease term
     or the estimated useful life of the asset.  Costs of the integrated managed
     care information system are amortized using the straight-line method over a
     seven-year period.

     NET INCOME PER SHARE

     The  Company  accounts  for net  income  per share in  accordance  with the
     provisions  of Statement of  Accounting  Standards  No. 128  "Earnings  per
     Share" (SFAS 128. In accordance  with SFAS 128,  basic net income per share
     is  computed  by  dividing  net income,  after  deducting  preferred  stock
     dividends  requirements  (if any), by the weighted average number of shares
     of common stock outstanding.

     Diluted  net income per share  reflects  the  maximum  dilution  that would
     result after giving  effect to dilutive  stock  options and warrants and to
     the assumed conversion of all dilutive convertible securities and stock.

     Weighted  average  outstanding  shares do not  include  shares  held by the
     Employee Stock Ownership Plan at July 31, 1999 and 1998. Shares held by the
     ESOP are not considered  outstanding for net income per share  calculations
     until the shares are released to the employees accounts.

     STOCK OPTION PLAN

     The  Company  accounts  for its stock  option plan in  accordance  with the
     provisions of SFAS No. 123, ACCOUNTING FOR STOCK-BASED COMPENSATION,  which
     permits  entities to recognize as expense over the vesting  period the fair
     value of all stock-based awards on the date of grant.  Alternatively,  SFAS
     No. 123 also allows entities to apply the provisions of APB Opinion No. 25,
     ACCOUNTING  FOR STOCK  ISSUED TO  EMPLOYEES,  and  related  operations  and
     provide pro forma net income and pro forma  earnings per share  disclosures
     for employee stock option grants as if the fair-value-based  method defined
     in SFAS No. 123 had been  applied.  The  Company  has  elected to apply the
     provisions  of APB  Opinion  No. 25 and  provide  the pro forma  disclosure
     provisions of SFAS No. 123.

                                       19
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements

     INCOME TAXES

     Deferred tax assets and liabilities are recognized for the estimated future
     tax  consequences   attributable  to  differences   between  the  financial
     statement  carrying  amounts of existing  assets and  liabilities and their
     respective  tax bases.  Deferred  tax assets and  liabilities  are measured
     using  enacted  tax rates in effect for the year in which  those  temporary
     differences are expected to be recovered or settled.

     IMPAIRMENT OF LONG-LIVED ASSETS

     SFAS No. 121,  ACCOUNTING FOR THE  IMPAIRMENT OF LONG-LIVED  ASSETS AND FOR
     LONG-LIVED  ASSETS TO BE DISPOSED OF, requires that  long-lived  assets and
     certain identifiable intangibles be reviewed for impairment whenever events
     or changes in  circumstances  indicate that the carrying amount of an asset
     may not be  recoverable.  Recoverability  of  assets to be held and used is
     measured by a comparison  of the carrying  amount of an asset to future net
     cash  flows  expected  to be  generated  by the asset.  If such  assets are
     considered to be impaired,  the  impairment to be recognized is measured by
     the  amount by which the  carrying  amount of the assets  exceeds  the fair
     value of the assets.  Assets to be disposed of are reported at the lower of
     the carrying amount or fair value less costs to sell.

     FAIR VALUE OF FINANCIAL INSTRUMENTS

     Fair value estimates of financial  instruments are made at a specific point
     in time and are based on relevant market  information and information about
     the  financial  instrument;  they are  subjective  in  nature  and  involve
     uncertainties and matters of judgment and, therefore,  cannot be determined
     with precision.  Changes in assumptions  could  significantly  affect these
     estimates and, since the fair values are estimated as of July 31, 1999, the
     amounts that will actually be realized or paid at settlement or maturity of
     the  instruments  could be  significantly  different.  The Company does not
     trade in derivative financial instruments.

     Management  believes that the recorded amount of current assets and current
     liabilities  approximate  fair value because of the short maturity of these
     instruments.  The recorded  balance of  long-term  debt  approximates  fair
     value, as the terms of the debt are similar to rates  currently  offered to
     the Company for similar debt instruments.

     USE OF ESTIMATES

     Management has made a number of estimates and  assumptions  relating to the
     reporting of assets and  liabilities,  disclosure of contingent  assets and
     liabilities,  and the  reporting of revenues and expenses to prepare  these
     financial  statements  in conformity  with  generally  accepted  accounting
     principles. Actual results could differ from those estimates.

     RECLASSIFICATION

     Certain accounts  related to prior years have been  reclassified to conform
     to current year presentation.

                                       20
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements

(2)  MARKETABLE INVESTMENT SECURITIES

     At July 31, 1999, the actual cost, net of unrealized holding losses and the
     fair value of available-for-sale  securities were as follows. There were no
     material realized gains or losses included in income in 1999.

                                              NET UNREALIZED
                                  COST        HOLDING LOSSES     FAIR VALUE
                                ---------     --------------     ----------

          Equity Securities     $ 250,772        (10,897)         239,875
                                =========        =======          =======

(3)  NOTE RECEIVABLE - OFFICER

     The Company has an outstanding  note  receivable due from the President and
     Chief Executive Officer.  The note is secured by an insurance policy on the
     life of the  officer.  The terms of the note  require  annual  installments
     through  August  1,  1999.  The  balance  of the note on July 31,  1999 was
     $28,794.

(4)  LEASE OBLIGATIONS

     The Company  operates from leased premises under operating  leases.  Rental
     expense related to these leases was $299,175 in 1999 and $289,712 in 1998.

     Future minimum lease payments under  noncancelable  operating  leases as of
     July 31, 1999 are as follows:

              YEARS ENDING JULY 31,
                      2000                          $ 299,216
                      2001                            312,610
                      2002                            320,984
                      2003                             53,730
                                                    ---------

                                                    $ 986,540
                                                    =========

(5)  NET INCOME PER SHARE

     Options for 29,271  shares of common stock were included in diluted EPS for
     1999.  Options to  purchase  193,550  shares of common  stock at an average
     price of $5.92 were  outstanding  at July 31, 1999 but were not included in
     the  computation  of diluted EPS because the  options'  exercise  price was
     greater than the average market price of the common shares.

(6)  STOCK OPTIONS

     The Company  maintains a stock  option plan (the  "Plan")  which covers all
     employees,  officers,  executives,  and directors of, and  consultants  and
     advisors to the  Company and  provides  for the  granting of  non-qualified
     stock options.

                                       21
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements

     The Company has reserved  300,000  shares of common stock for issuance upon
     exercise of stock options granted under the plan.

     Options are granted at not less than fair market value on the date of grant
     and become  exercisable  based on conditions set by the Board of Directors.
     Options generally expire if unexercised at the end of five years.

     The  Company's  previous  stock  option plan which  covered all  employees,
     officers  and  directors  of the Company and  provided  for the granting of
     incentive and  non-qualified  stock  options  expired on December 31, 1997,
     however, under the Plan, all outstanding options that were granted prior to
     the Plan  expiration  continue in full force and effect until  exercised or
     expired  under the  provisions  of the Plan as if the Plan had  remained in
     full force and effect.

     As previously discussed, the Company applies APB Opinion No. 25 and related
     interpretations  in accounting for the Plan.  Accordingly,  no compensation
     cost has been  recognized  for the  Plan.  Had  compensation  costs for the
     Company's plan been determined  consistent with FASB Statement No. 123, the
     Company's  net income and net income per share  would have been the same as
     those reported.

     At July 31, 1999, 272,500 stock options were available for grant under this
     plan and 181,902 stock options were exercisable.  Activity related to stock
     options is summarized, as follows:

<TABLE>
<CAPTION>
                                INCENTIVE STOCK OPTIONS    NONQUALIFIED STOCK OPTIONS
                                -----------------------    --------------------------
                                              WEIGHTED                      WEIGHTED
                                              AVERAGE                       AVERAGE
                                              OPTION                        OPTION
                                 NUMBER      PRICE PER       NUMBER        PRICE PER
    DATE         ACTIVITY       OF SHARES      SHARE        OF SHARES        SHARE
    ----         --------       ---------      -----        ---------        -----
<S>             <C>             <C>         <C>              <C>        <C>
July 31, 1997   Outstanding       43,135      $  4.69          250,000      $  4.37
                Granted               --           --           17,500         3.31
                Exercised             --           --          (20,000)        1.31
                Expired           (8,733)        5.60               --           --
                                --------      -------      -----------      -------
July 31, 1998   Outstanding       34,402         4.83          247,500         4.09
                Granted               --           --           27,500         4.97
                Exercised             --           --          (40,000)        1.91
                Expired           (5,000)        6.00          (50,000)        6.15
                                --------      -------      -----------      -------
July 31, 1999   Outstanding       29,402      $  3.60          185,000      $  4.81
                                ========      =======      ===========      =======
                Exercisable       29,402                       152,500
                                ========                   ===========
</TABLE>

     The  Company  realizes  an income tax  benefit  from the  exercise or early
     disposition of certain stock options. For financial reporting purposes, the
     tax effect of this  deduction  is accounted  for an increase in  additional
     paid-in  capital,  rather than as a reduction of income tax expense.  A tax
     benefit of approximately $33,333 was recognized for the year ended July 31,
     1999.

                                       22
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements

(7)  EMPLOYEE STOCK OWNERSHIP PLAN

     The Company maintains an employee stock ownership plan (ESOP), qualified as
     a stock bonus plan under Section  401(a) of the Internal  Revenue Code. The
     Plan is designed to invest  primarily in Company stock  exclusively for the
     benefit of eligible  employees of the Company.  Eligible  employees  become
     participants  in the Plan upon completion of one year of service as defined
     by  the  Plan.  Company  contributions  are  determined  each  year  by the
     Company's  Board of  Directors  (subject  to certain  limitations)  and are
     allocated  among the accounts of  participants in proportion to their total
     compensation.

     During fiscal 1995, the Trust  borrowed  $422,000 from a bank for a term of
     five years at an annual  interest rate of 8.42%.  The proceeds,  along with
     the Company's 1994 ESOP contribution, were used to purchase 91,978 treasury
     shares from the Company.  Because the Company has guaranteed the bank loan,
     it is  reported as debt of the  Company.  The shares sold by the Company to
     the  Trust  are   reflected  in   shareholders'   equity,   and  an  amount
     corresponding to the borrowing (the guaranteed ESOP obligation) is reported
     as a reduction of shareholders'  equity.  At July 31, 1999, the fair market
     value of the 3,220  unearned  ESOP shares was $11,070.  The loan  agreement
     requires  quarterly  payments of principal and interest  which will be paid
     from the Company's  contributions  to the ESOP. As the principal  amount of
     the borrowing is repaid,  the liability and the guaranteed  ESOP obligation
     are  reduced.  The Company  recognizes  compensation  expense  equal to the
     average  fair  market  value of the shares  committed  to be  released  for
     allocation  to  participants  in the  ESOP,  which is  based on total  debt
     service requirements. Such expense amounted to $50,771 for 1999 and $59,951
     for 1998.

     Minimum  remaining  principal payment required to be made during the fiscal
     year ending July 31, 2000 is $21,100.

(8)  EMPLOYEE BENEFIT PLAN

     The Company has a qualified  401(k) plan (defined  contribution  plan). The
     plan covers  substantially  all employees who have completed at least three
     months of  service  and  attained  age 18.  Subject  to limits  imposed  by
     Internal  Revenue  Service  regulations  and other options  retained by the
     Company affecting  participant  contribution,  participants may voluntarily
     contribute  a  percentage  of  their  annual  wages  not to  exceed  limits
     established  by the Tax Reform Act of 1986.  Participants  are  immediately
     vested in the amount of their  direct  contribution.  The Company  does not
     contribute to the plan.

                                       23
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements

(9)  INCOME TAXES

     Components of income tax expense for the years ended July 31, 1999 and 1998
     include:

                                         CURRENT         DEFERRED         TOTAL
                                         -------         --------         -----
     1999:
         Federal (Restated)             $  98,749          95,938        194,687
         State (Restated)                   8,117          22,131         30,248
                                        ---------         -------        -------

                                        $ 106,866         118,069        224,935
                                        =========         =======        =======
     1998:
         Federal                        $ (56,616)        245,565        188,949
         State                            (15,012)         65,112         50,100
                                        ---------         -------        -------

                                        $ (71,628)        310,677        239,049
                                        =========         =======        =======

     Actual tax expense  differs from the  "expected"  tax expense  (computed by
     applying the applicable  U.S.  Federal  corporate tax rate of 34% to income
     before income taxes) as follows:

                                                          1999            1998
                                                       ----------        -------
                                                       (Restated)

Computed "expected" tax expense                         $ 214,989        200,521
Increase (reduction) in income taxes resulting from:
 Effect of permanent items                                (37,622)        33,066
 State income taxes, net of Federal benefit                47,568          5,462
                                                        ---------        -------

                                                        $ 224,935        239,049
                                                        =========        =======

                                       24
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements

     The  temporary  differences  that  give rise to  deferred  tax  assets  and
     liabilities at July 31, 1999 (Restated) include:

         Deferred tax assets:
           Bad debt reserve                                          $   14,694
           Accrued expenses                                              95,006
                                                                     ----------
              Total gross deferred tax assets                           109,700

           Less valuation allowance                                          --
                                                                     ----------
              Net deferred tax asset                                    109,700

         Deferred tax liabilities:
           Deferred costs                                              (697,983)
           Accelerated depreciation                                     (26,588)
           Prepaid expenses                                             (53,139)
           Other                                                        (25,684)
                                                                     ----------
               Total gross deferred tax liabilities                    (803,394)
                                                                     ----------
               Net deferred tax liability                            $ (693,694)
                                                                     ==========

     In assessing the realizability of deferred tax assets, management considers
     whether it is more likely than not that some portion or all of the deferred
     tax assets will not be realized.  Accordingly,  the Company has  determined
     that a valuation  allowance is not necessary and there was no change in the
     valuation allowance during the year ended July 31, 1999.

(10) BUSINESS SEGMENTS AND MAJOR CUSTOMERS

     The Company's  operations are in one business segment throughout the United
     States - the  development  and  marketing  of vision care  cost-containment
     programs. One customer accounted for 4% of revenues during fiscal 1999.

     The Company operates in a very competitive market. The Company's success is
     dependent  upon the  ability of its  marketing  group,  and its  network of
     agents,   to  identify  and  contract  with  businesses  and  organizations
     nationwide,  and to administer  its networks.  Changes in the insurance and
     health care  industries,  including the  regulation  thereof by federal and
     state agencies,  may  significantly  affect  management's  estimates of the
     Company's performance.

     The allowance for doubtful accounts is based on the creditworthiness of the
     Company's   customers  as  well  as  consideration   for  general  economic
     conditions.  Consequently,  an adverse change in those factors could affect
     the Company's estimate of its bad debts.

                                       25
<PAGE>
              FIRST AMERICAN HEALTH CONCEPTS, INC. AND SUBSIDIARIES

                   Notes to Consolidated Financial Statements

(11) COMMITMENTS AND CONTINGENCIES

     The Company is subject to various claims and litigation  arising out of the
     ordinary course of business. In the opinion of management,  the Company has
     adequate  legal  defenses  and  the  outcome  of  those  matters  will  not
     materially effect the Company's financial position.

     Certain  agreements with customer  companies and networks are cancelable at
     the option of those parties with written  notice which varies from 30 to 90
     days.  Management  generally  attempts  to  renegotiate  any such  canceled
     agreements.  Management  believes that there is very little likelihood that
     there would be  cancellations  sufficient to have a material adverse effect
     on the Company's results of operations or financial condition.

     Management  has  developed a plan to address the Year 2000  problem and all
     computer  systems  are  in  the  process  of  conversion  to be  Year  2000
     compliant.  The Year 2000 problem is the result of computer  programs being
     written using two digits  rather than four digits to define the  applicable
     year.  The total cost of the  project is not  material  and the  Company is
     expensing all associated costs as they are incurred.

(12) RESTATEMENT

     During  2000,  subsequent  to the issuance of the  Company's  July 31, 1999
     audited consolidated  financial  statements,  certain accounting items that
     affect those consolidated financial statements were identified as requiring
     adjustment.

     The  need  for  adjustment  was  identified  in  the  following  items:  an
     unrecorded claims reserve of $261,000;  a tax credit of $109,000 originally
     recorded in fiscal  1999 that the  Company now knows will not be  realized;
     and adjustments further reducing general expenses by $171,000. In addition,
     $163,000 of costs were  identified  that do not qualify for deferral.  This
     item only affects retained earnings accumulated in prior years.

     After  restatement of these items, the net income of the Company is reduced
     by $165,000 ($0.06 per share) in fiscal 1999.  Financial statement balances
     and footnote presentation have been restated accordingly.

                                       26


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission